Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP & GENERAL COUNSEL
Mar 19, 2026
Sale
Shares
80
Price
$533.41
Total Value
$42.67K
Shares Held After
45,172
% of Holdings
0.2%

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP & GENERAL COUNSEL
Mar 19, 2026
Sale
Shares
650
Price
$532.50
Total Value
$346.12K
Shares Held After
45,252
% of Holdings
1.4%

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP & GENERAL COUNSEL
Mar 19, 2026
Sale
Shares
794
Price
$531.62
Total Value
$422.11K
Shares Held After
45,902
% of Holdings
1.7%

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP & GENERAL COUNSEL
Mar 19, 2026
Sale
Shares
1,776
Price
$530.63
Total Value
$942.41K
Shares Held After
46,696
% of Holdings
3.7%

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP & GENERAL COUNSEL
Mar 19, 2026
Sale
Shares
2,808
Price
$529.82
Total Value
$1.49M
Shares Held After
48,472
% of Holdings
5.5%

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP & GENERAL COUNSEL
Mar 19, 2026
Sale
Shares
1,439
Price
$528.41
Total Value
$760.38K
Shares Held After
51,280
% of Holdings
2.7%

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP & GENERAL COUNSEL
Mar 19, 2026
Sale
Shares
753
Price
$527.47
Total Value
$397.18K
Shares Held After
52,719
% of Holdings
1.4%
Version: v26.3.33